Sema3A(aa363-377) -kLytic
General Information
DRACP ID DRACP01384
Peptide Name Sema3A(aa363-377) -kLytic
Sequence NYQWVPYQGRVPYPRGGGKLLLKLLKKLLKlLKKK
Sequence Length 35
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Cancer targeted peptides
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
BXPC-3 | Pancreatic ductal adenocarcinoma | Carcinoma | IC50=5.7±2.3μM | WST-8 assay | 48h | Patent |
CFPAC-1 | Cystic fibrosis; Pancreatic ductal adenocarcinoma; Cystic fibrosis | Carcinoma | IC50=6.7±0.1μM | WST-8 assay | 48h | Patent |
PANC-1 | Pancreatic ductal adenocarcinoma | Carcinoma | IC50=13±2.7μM | WST-8 assay | 48h | Patent |
SU.86.86 | Pancreatic adenocarcinoma | Carcinoma | IC50=5.2±0.4μM | WST-8 assay | 48h | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Pancreatic epithelium: IC50>20μM; MRC-5: IC50>50μM; Human normalhepatocyte cell: IC50=37.5μM
Target Epidermal growth factor receptor (EGFR)
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification l=D-Leucine; k=D-Lysine
Chiral Mix
Physicochemical Information
Formula C193H318N52O40
Absent amino acids ACDEFHIMST
Common amino acids KL
Mass 461361
Pl 11.3
Basic residues 10
Acidic residues 0
Hydrophobic residues 11
Net charge 10
Boman Index -3885
Hydrophobicity -66
Aliphatic Index 105.71
Half Life
/
Extinction Coefficient cystines 9970
Absorbance 280nm 293.24
Polar residues 8
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2011/0319336 A1
Patent Title Selective anticancer chimeric peptide.
Other Iinformation Granted Patent Family: 19s / 19ex; Family Jurisdictions: US, JP, EP, WO, CN; Legal Status: Active; Application No: 200913132580; Filed: Dec 3, 2009; Published: Dec 29, 2011; Earliest Priority: Dec 3, 2008; Granted: May 7, 2013
Other Published ID CN102238965A EP2370107A2 WO2010064207A2 WO2010064207A3